| For: | Lin WC, Lin K, Li MK, Liu X, Huang YF, Wang X, Wu B. Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients. World J Hepatol 2024; 16(11): 1321-1330 [PMID: 39606169 DOI: 10.4254/wjh.v16.i11.1321] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i11/1321.htm |
| Number | Citing Articles |
| 1 |
Heng Ma, Lihua Yu, Xiaoli Liu, Huiwen Yan, Yuqing Xie, Zimeng Shang, Guangyuan Huo, Wanxin Shi, Zhe Zhang, Zhiyun Yang. Baseline low-level viremia in HBV-related hepatocellular carcinoma: prognostic significance, risk stratification, and clinical implications. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1900644
|
| 2 |
Qun Yang, Jie Zheng, Jinheng Cao. Letter: More Precise Stratification Is Needed Within Chronic Hepatitis B Virus Low‐Level Viraemia. Alimentary Pharmacology & Therapeutics 2026; doi: 10.1111/apt.70724
|
| 3 |
Xiaoqin Yuan, Xinyi Xiang, Hongqian Xu, Wencen Lu, JinJing Zhang, Zhili Hu, Shiying Li, Li Zhou. A machine learning model for predicting complete virological response in chronic hepatitis B patients receiving first-line nucleos(t)ide analogues therapy. Journal of Clinical Virology 2026; 183 doi: 10.1016/j.jcv.2026.105921
|
| 4 |
颜 刘. Current Status and Prospects of Clinical Research on Low-Level Viremia in Chronic Hepatitis B after Treatment. Advances in Clinical Medicine 2026; 16(03) doi: 10.12677/acm.2026.163981
|